- Home
- Urologic Oncology
- CRPC w/ bone metastases
The Latest Research on CRPC with Bone Metastases
Recent Abstracts
-
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.CRPC w/ bone metastasesMay 17, 2018
-
Radiation for Treatment of Painful Bone Metastases.CRPC w/ bone metastasesMay 15, 2018
-
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases.CRPC w/ bone metastasesMarch 20, 2018
-
Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy.CRPC w/ bone metastasesMarch 20, 2018
-
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.CRPC w/ bone metastasesMarch 14, 2018
-
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer.CRPC w/ bone metastasesMarch 14, 2018
-
Radium-223 international early access program: results from the Spanish subset.CRPC w/ bone metastasesMarch 14, 2018
-
Utility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223.CRPC w/ bone metastasesMarch 14, 2018
-
Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients.CRPC w/ bone metastasesMarch 12, 2018
-
Launch of Oncotype DX® AR-V7 Nucleus Detect™ Test Expands Offering to Prostate Cancer Patients - Predicting Treatment Response in Metastatic DiseaseCRPC w/ bone metastasesFebruary 26, 2018
Beyond the Abstracts
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015